New study paves way for future treatments in rare brain disorder
NCT ID NCT06018519
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with creatine transporter deficiency, a rare genetic condition that causes intellectual disability, seizures, and movement problems. Researchers want to find the best tests to measure symptoms, since many standard tests are too hard for these patients. The goal is to prepare for future clinical trials of new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CREATINE TRANSPORTER DEFECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Woman, mother and child hospital, Hospices Civils de Lyon
RECRUITINGBron, 69500, France